Medindia LOGIN REGISTER
Medindia

Side effect(s) of Eribulin Mesylate


Review the side-effects of Eribulin Mesylate as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the instances these side-effects are mild and easily tolerable, however sometimes they can be more severe and can be detrimental.

If the side effects are not tolerable adjusting the dosage or switching to a different medication can help to manage or overcome side effects. If you have any doubts or questions, we recommend seeking advice from your doctor or pharmacist.

   Most Common
- Decrease in white blood cells, anemia, weakness, fatigue, hair loss, nerve disease, nausea, and constipation.

   Central Nervous system
- Headache.

   General
- Weakness, fatigue and fever.

   Gastrointestinal
- Diarrhea and vomiting.

   Musculoskeletal
- Joint/muscle pain, back pain, bone pain and pain in extremity.

   Metabolic
- Loss of appetite and decreased weight.

   Respiratory
- Cough and difficulty in breathing.

   Genitourinary
- Urinary tract infection.

Other Precautions :

Avoid excess dosage.

Drug Name : Eribulin Mesylate

Eribulin Mesylate(Halaven) generic is an anticancer agent, prescribed for breast cancer. It prevents the growth and spread of cancer cells in the body.


Trade Names for Eribulin Mesylate

International :


Halaven
Advertisement